COVID-19 Testing Flashcards

1
Q

SARS CoV-2

A
  • related to SARS CoV-1
  • enveloped
  • (+) ssRNA virus
  • 60-140 nm
  • 29.9 kb with 14 ORFs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

transmission of coronavirus

A

respiratory droplets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

the national case definition of COVID-19 required at ____ gene targets to be detected

A

2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

E gene assay

A

more sensitive, cross-reacts with SARS-CoV-1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

RdRp gene assay

A

less sensitive but more specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

easyMag most suitablee use

A

lower resp samples (viscous(

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

this is most suitable everything else

A

MagMax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hamilton Starlet

A

too slow so tried for sampling pooling but takes 3 hours; doesnt work for workflow of doing thousands of tests a day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

variant of concern

A

demonstrated to be associated with increased transmissibility or virulence, or reduced effectiveness ff public health measurs, available diagnostics, vaccines, or therapeutics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

variant of interest

A

has genetic changes predicted or known to affect viral characteristics, and identified as cause of insignificant community transmission or multiple disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

most sensitive tests for respiratory viruses

A

molecular testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T or F. pan coronavirus RT-PCR is gel-based.

A

T
- obtained primers for a gel-based SARS-CoV-2 specific RT-PCR based on the RdRp gene sequence and performed a quick evaluation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how to test for analytical specificity?

A

pathogens that can be encountered in pt samples where illness may be similar were tested by both E and RdRp gene assays
- cross rxn only observed in E gene assay for the original SARS-CoV (as expected)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When the E and RdRp gene assays were implemented, what was done to confirm test performance?

A

first 100 neg samples and 10 pos samples confirmed by sending to NML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

initial covid-19 test

A

Pan-coronavirus RT-PCR (gel-based)

obtained primers for a gel-based SARS-CoV-2 specific RT-PCR based on the RdRp gene sequence and performed a quick evaluation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

advantages of real time PCR

A

easy to interpret, run, automate, and scale up to high test volumes

considerations:
- analytical sensitivity (limit of detection)
- analytical specificity (cross-reactivity)
- accuracy
- precision
- where to find positive and negative samples???
- what test to use to compare results (ie, gold std?)

17
Q

analytical sensitivity test

A

known conctns of in-vitro RNA were each tested nine times and probit (pos/neg) analysis was performed

18
Q

multiplex assays

A

created in March to increase capacity (before, could only run 32 samples on a 96-well plate)
- E, RdRp and internal control all in one well, all 96 wells could be used

19
Q

multiplex challenges

A
  • RdRp gene with high background and an early CT value
  • E gene with high background and a late CT value
20
Q

why did the gene target requirement change to just one?

A

COVID-19 less rare = became less important to confirm ever sample with two gene targets

  • wanted to get rid of high background
  • replaced FAM dye with NED dye (less intense so less background and less false pos)
21
Q

quadplex assay

A

fall 2021; influenza szn
- introduce influenza testing while maintaining COVID-19 diagnostics
- four targets in a single PCR reaction = SARS-CoV-2, influenza A, influenza B, internal control

22
Q
A